Chapter 1. Point of Care Testing For Intestinal Protozoa Market – Scope & Methodology
1.1 Market Segmentation
1.2 Scope, Assumptions & Limitations
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
Chapter 2. Point of Care Testing For Intestinal Protozoa Market – Executive Summary
2.1 Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2 Key Trends & Insights
2.2.1 Demand Side
2.2.2 Supply Side
2.3 Attractive Investment Propositions
2.4 COVID-19 Impact Analysis
Chapter 3. Point of Care Testing For Intestinal Protozoa Market – Competition Scenario
3.1 Market Share Analysis & Company Benchmarking
3.2 Competitive Strategy & Development Scenario
3.3 Competitive Pricing Analysis
3.4 Supplier-Distributor Analysis
Chapter 4. Point of Care Testing For Intestinal Protozoa Market Entry Scenario
4.1 Regulatory Scenario
4.2 Case Studies – Key Start-ups
4.3 Customer Analysis
4.4 PESTLE Analysis
4.5 Porters Five Force Model
4.5.1 Bargaining Power of Suppliers
4.5.2 Bargaining Powers of Customers
4.5.3 Threat of New Entrants
4.5.4 Rivalry among Existing Players
4.5.5 Threat of Substitutes
Chapter 5. Point of Care Testing For Intestinal Protozoa Market – Landscape
5.1 Value Chain Analysis – Key Stakeholders Impact Analysis
5.2 Market Drivers
5.3 Market Restraints/Challenges
5.4 Market Opportunities
Chapter 6. Point of Care Testing For Intestinal Protozoa Market – By Age Group
6.1 Introduction/Key Findings
6.2 Children
6.3 Adult
6.4 Geriatric
6.5 Y-O-Y Growth trend Analysis By Age Group
6.6 Absolute $ Opportunity Analysis By Age Group, 2024-2030
Chapter 7. Point of Care Testing For Intestinal Protozoa Market – By Technology
7.1 Introduction/Key Findings
7.2 Molecular Diagnostics
7.3 Microscopy
7.4 Immunochromatography
7.5 Others
7.6 Y-O-Y Growth trend Analysis By Technology
7.7 Absolute $ Opportunity Analysis By Technology, 2024-2030
Chapter 8. Point of Care Testing For Intestinal Protozoa Market – By End-User
8.1 Introduction/Key Findings
8.2 Hospitals & Clinics
8.3 Health Care Centers
8.4 Home-Care Testing Kits
8.5 Others
8.6 Y-O-Y Growth trend Analysis By End-User
8.7 Absolute $ Opportunity Analysis By End-User, 2024-2030
Chapter 9. Point of Care Testing For Intestinal Protozoa Market , By Geography – Market Size, Forecast, Trends & Insights
9.1 North America
9.1.1 By Country
9.1.1.1 U.S.A.
9.1.1.2 Canada
9.1.1.3 Mexico
9.1.2 By Age Group
9.1.3 By End-User
9.1.4 By TechnologyFactor
9.1.5 Countries & Segments - Market Attractiveness Analysis
9.2 Europe
9.2.1 By Country
9.2.1.1 U.K
9.2.1.2 Germany
9.2.1.3 France
9.2.1.4 Italy
9.2.1.5 Spain
9.2.1.6 Rest of Europe
9.2.2 By Age Group
9.2.3 By End-User
9.2.4 By TechnologyFactor
9.2.5 Countries & Segments - Market Attractiveness Analysis
9.3 Asia Pacific
9.3.1 By Country
9.3.1.1 China
9.3.1.2 Japan
9.3.1.3 South Korea
9.3.1.4 India
9.3.1.5 Australia & New Zealand
9.3.1.6 Rest of Asia-Pacific
9.3.2 By Age Group
9.3.3 By End-User
9.3.4 By TechnologyFactor
9.3.5 Countries & Segments - Market Attractiveness Analysis
9.4 South America
9.4.1 By Country
9.4.1.1 Brazil
9.4.1.2 Argentina
9.4.1.3 Colombia
9.4.1.4 Chile
9.4.1.5 Rest of South America
9.4.2 By Age Group
9.4.3 By End-User
9.4.4 By TechnologyFactor
9.4.5 Countries & Segments - Market Attractiveness Analysis
9.5 Middle East & Africa
9.5.1 By Country
9.5.1.1 United Arab Emirates (UAE)
9.5.1.2 Saudi Arabia
9.5.1.3 Qatar
9.5.1.4 Israel
9.5.1.5 South Africa
9.5.1.6 Nigeria
9.5.1.7 Kenya
9.5.1.8 Egypt
9.5.1.9 Rest of MEA
9.5.2 By Age Group
9.5.3 By End-User
9.5.4 By TechnologyFactor
9.5.5 Countries & Segments - Market Attractiveness Analysis
Chapter 10. Point of Care Testing For Intestinal Protozoa Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1 Cardinal Health
10.2 Seamaty
10.3 Biomeriux
10.4 Goffin Molecular Technologies
10.5 BioFire Diagnostics
10.6 Biolab Diagnostics
10.7 Openron
10.8 Nal Von Minden GmbH
2850
5250
4500
1800
Frequently Asked Questions
The Point of Care Testing For Intestinal Protozoa Market was valued at USD 238.5 Million and is projected to reach a market size of USD 415.96 Million by the end of 2030.
Increased demand for on-site diagnosis and Rising trends in telehealth are the market drivers of the point-of-care testing For Intestinal Protozoa market.
Molecular Diagnostics, Microscopy, Immunochromatography, and Others, are the segments under the Point of Care Testing For Intestinal Protozoa Market by technology.
North America is the most dominant region for the Point of Care Testing For Intestinal Protozoa Market.
Asia-Pacific is the fastest-growing region in the Point of Care Testing For Intestinal Protozoa Market.